Skip to main content
HHS
NASDAQ Trade & Services

Harte Hanks to Be Acquired by Star Equity for $5.00/Share — 100% Premium, 30-Day Go-Shop

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Positive
Importance info
9
Price
$3.79
Mkt Cap
$28.177M
52W Low
$2
52W High
$4.5
52W Position info
90% above low
Off High info
16% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

HHS sits 90% above its 52-week low of $2 on elevated volume (2.3× avg).

Summary

Harte Hanks agreed to be acquired by Star Equity Holdings for $5.00 per share in cash or preferred stock, a 100% premium. The deal includes a 30-day go-shop period and is expected to close in 60-90 days.


Key Events · M&A and Partnerships · HHS

  • Definitive Merger Agreement Signed

    On August 14, 2026, Harte Hanks entered into a merger agreement with Star Equity Holdings. Shareholders will receive $5.00 per share in cash or 0.50 shares of Star Equity 10% Series A Cumulative Perpetual Preferred Stock (liquidation preference $10.00).

  • 100% Premium to Unaffected Price

    The $5.00 per share offer represents an approximately 100% premium to Harte Hanks' unaffected share price, delivering immediate value to shareholders.

  • Cash Consideration Capped at $19.2M

    The aggregate cash consideration is capped at $19.2 million, with the remainder payable in Star Equity preferred stock. Elections are subject to proration if cash elections exceed the cap.

  • 30-Day Go-Shop Period

    Harte Hanks may actively solicit alternative acquisition proposals until September 13, 2026. The board may continue discussions with qualifying parties after that date.


Analysis · HHS · Trade & Services

A definitive merger agreement with Star Equity Holdings values Harte Hanks at $5.00 per share, a 100% premium to the unaffected price. Shareholders may elect cash or Star Equity preferred stock, subject to a $19.2 million cash cap. The deal includes a 30-day go-shop period, a $1.15 million termination fee, and requires debt financing of up to $15 million. This is a transformative event for the company, providing immediate liquidity and a path to address structural challenges as a small public company.

At the time of this filing, HHS was trading at $3.79 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $28.2M. The 52-week trading range was $2.00 to $4.50. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HHS - Latest Insights

HHS
Aug 14, 2026, 5:08 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $4.22
Real-time Price: $3.87 info
Change: -$0.350 (-8%) info
Market Cap: $28.177M info
HHS
May 15, 2026, 8:16 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $3.87 info
Change: +$1.06 (+38%) info
Market Cap: $28.177M info
HHS
May 14, 2026, 4:24 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $3.87 info
Change: +$1.06 (+38%) info
Market Cap: $28.177M info
HHS
Mar 17, 2026, 5:20 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $2.67
Real-time Price: $3.87 info
Change: +$1.20 (+45%) info
Market Cap: $28.177M info